Media Statement on nuclear medicine production
The supply of lutetium-177 from the OPAL multi-purpose reactor for an advanced stage prostate cancer clinical trial has garnered considerable media interest today.
ANSTO is proud to be contributing to clinical trials by providing radioactive substances as imaging agents or as therapies. This weekend staff join the Cronulla Relay For Life event.
ANSTO was closely associated with the 12th Congress of World Federation of Nuclear Medicine and Biology because of its diverse contribution as a member of the nuclear medicine community
Dr Ben Fraser attended the 12th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) that was held in Melbourne (20-24 April), to present a poster entitled “[18F]D4-PBR111 - An Improved 2nd Generation Deuterated Radiotracer for Imaging Inflammation”
ANSTO is a partner organisation of the 12th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) being held in Melbourne.
ANSTO to reopen to staff tomorrow 18th, April. School holiday workshops, external tours cancelled until Monday.
In mid-2018, ANSTO, together with several State and Federal Government agencies, will undertake Australia’s 10th routine transport of spent nuclear fuel assemblies.
When Pamela Naidoo- Ameglio joined ANSTO six weeks ago as Group Executive, Nuclear Operations, she became the third female on the Executive Leadership Team.
ANSTO is providing expertise and irradiation services for Australian biomedical company OncoSil Medical